About Pharminox
Pharminox is an emerging UK company focused on the discovery and development of small molecule drugs for the treatment of cancer.
The Company’s internal drug discovery and in-licensing activities are target-driven and based on world-class medicinal chemistry, drug development and commercial expertise brought by an experienced team led by CEO Peter Worrall (ex Vernalis, British Biotech), CSO Professor Malcolm Stevens (former Director of the Cancer Research UK Experimental Cancer Chemotherapy Group) and Head of Chemistry Mark Hummersone (ex KuDOS Pharmaceuticals).
Facts about Pharminox
Facts about Pharminox
- Focus : Manufacturer
- Industry : Pharma
